USPTO serial 79408925
KAI | EQ CO-PILOT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2026
- Examiner
- DAVIS, MARC STEPHEN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KAI | EQ CO-PILOT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard S. Finkelstein
Richard S. Finkelstein RC Trademark Company, LLC56 Danbury Road, Suite 9New Milford, CT 06776United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable AI software for the analysis of data in healthcare industry; VR goggles; downloadable artificial intelligence software for the analysis of data in healthcare industry; data processing apparatus with artificial intelligence for the analysis of data for managing customer interactions and providing automated customer support in healthcare industry by providing data on the acoustic, textual, and facial emotion aspects of conversations between healthcare or pharma professionals and patients; downloadable artificial intelligence software for surveillance of persons for healthcare and pharmaceutical purposes; downloadable artificial intelligence software for data analysis, namely analysis of non-verbal communication and patient satisfaction; downloadable artificial intelligence software for data analysis, namely analysis of acoustic, textual, and facial emotion aspects of conversations between healthcare or pharma professionals and patients; downloadable artificial intelligence software for healthcare, namely, software for recording vital signs and non-verbal communication; downloadable artificial intelligence and machine learning software for the analysis of data in healthcare industry; downloadable interactive software based on artificial intelligence for the analysis of data in healthcare industry, namely analysis of non-verbal communication and patient satisfaction; downloadable computer application software for use with wearable computer devices, namely, for recording health information; downloadable mobile applications for use with wearable computer devices, namely, for recording health information; downloadable machine learning software; downloadable machine learning software for healthcare, namely for analysis of non-verbal communication and patient satisfaction; all of the foregoing being limited to life sciences, pharmaceutical and healthcare applications; none of the above related to deploying conversational AI or chatbot functions, monitoring casino activities, fraud prevention or detection, advertising, banking, or completing and processing global trade and supply chain transactions | ACTIVE | — |
| 042 | Artificial intelligence technology consultancy in the healthcare and pharma fields; computer programming services for the analysis of data for managing customer interactions and providing automated customer support in healthcare industry by providing data on the acoustic, textual, and facial emotion aspects of conversations between healthcare or pharma professionals and patients; computer programming in the healthcare and pharma fields; data conversion of electronic information in the healthcare and pharma fields; data mining in the healthcare and pharma fields; design and development of computer software for evaluation and calculation of data in the healthcare and pharma fields; platform as a service featuring software for the analysis of data in healthcare industry, namely analysis of non-verbal communication and patient satisfaction; platform as a service featuring software for the analysis of data in healthcare industry, namely analysis of acoustic, textual, and facial emotion aspects of conversations between healthcare or pharmaceutical professionals and patients; platforms for artificial intelligence as software as a service featuring software for the analysis of data in healthcare industry, namely analysis of non-verbal communication and patient satisfaction; platforms for artificial intelligence as software as a service featuring software for the analysis of data in healthcare industry, namely analysis of acoustic, textual, and facial emotion aspects of conversations between healthcare or pharmaceutical professionals and patients; technology research in the field of artificial intelligence for healthcare and pharmaceutical applications; research in the field of artificial intelligence technology for use in healthcare and pharmaceutical fields; software as a service featuring computer software platforms for analysis of data in healthcare industry using artificial intelligence; software as a service featuring software for machine learning in the healthcare and pharmaceutical industries; software as a service featuring machine learning software for deep learning and deep neural computer networks in healthcare and pharmaceutical industries; software as a service featuring software for the analysis of data in healthcare industry; software development in the framework of software publishing in healthcare and pharmaceutical industries; providing online non-downloadable cloud computing software for the analysis of data in healthcare industry; all of the foregoing being limited to life sciences, pharmaceutical and healthcare fields; none of the above related to deploying conversational AI or chatbot functions, monitoring casino activities, fraud prevention or detection, advertising, banking, or completing and processing global trade and supply chain transactions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by KAI Conversations Limited
- Other trademarks owned by KAI Conversations Limited
- Other trademarks owned by KAI Conversations Limited
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named KAI | EQ CO-PILOT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 28, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 23, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 22, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 8, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 8, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 25, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 28, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 23, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 6, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 6, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 6, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 6, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 6, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 13, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 13, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 30, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 30, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 30, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 21, 2025 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Dec 7, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 12, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 11, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 8, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 7, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |